Featured News
701Wire StoriesIntroducing THE BRIJ – A World of Arts and Culture
Serendipity Arts announces THE BRIJ, a futuristic arts and culture centre in the National Capital Region that will host multiple creative projects...
- 555Wire Stories
Movers Buddy Reports Affordable Suburbs To Move To If You Want To Save On Rent In Melbourne And Sydney
MELBOURNE, Australia–(BUSINESS WIRE)–As rents continue to soar, Australian families are struggling more than ever before to find affordable housing. When asked about...
- 599Wire Stories
Dongying seeks trade opportunities in overseas markets
DONGYING, China–(BUSINESS WIRE)–Dongying, a city in East China’s Shandong province, has been helping local enterprises expand in international markets as part of...
- 553Wire Stories
A Third of Businesses Predict the Current Inflationary Environment to Last More Than Two Years – Taulia
SAN FRANCISCO–(BUSINESS WIRE)–A third of global businesses predict the current inflationary environment to continue for more than two years, according to new...
- 519News
Luxury beauty advisory SWISS REJU wins COSMOPOLITAN Best of the Best Panel’s Choice Award, celebrating exceptional body contouring results
HONG KONG SAR – Media Outreach – 19 December 2022 – Luxury beauty advisory SWISS REJU has been honored with “Best of...
- 573News
Hong Kong Baptist University develops new aptamer drug for bone anabolic therapies
HONG KONG SAR – Media OutReach – 19 December 2022 – A research team led by Hong Kong Baptist University (HKBU) has...
- 528News
LOFTER Group assisted with “Gingko House”, the social enterprise, to hold a series of activities to bring warmth to the community this winter
HONG KONG SAR – Media OutReach – 19 December 2022 – LOFTER GROUP (“LOFTER” or “the Group”), a Hong Kong-based property developer...
- 814Wire Stories
ENHERTU® Recommended for Approval in the EU by CHMP for Patients with HER2 Low Metastatic Breast Cancer
Daiichi Sankyo and AstraZeneca’s ENHERTU is the first HER2 directed therapy to demonstrate a significant survival benefit versus chemotherapy in this patient...
- 753Wire Stories
ENHERTU® Approved in the EU for Patients with Previously Treated HER2 Positive Advanced Gastric Cancer
First HER2 directed medicine to be approved for gastric cancer in the EU in more than a decade Based on DESTINY-Gastric02 and...
- 607Wire Stories
Mitsubishi Electric to Delist Shares on London Stock Exchange
TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO:6503) announced today that it has decided to apply for the delisting of its shares of common stock...
- 608Wire Stories
Toshiba to Expand Power Semiconductor Production Capacity with New Production Facility
KAWASAKI, Japan–(BUSINESS WIRE)–Toshiba Electronic Devices & Storage Corporation (“Toshiba”) today announced that it will construct a new back-end production facility for power...
